Search Results for "Immunotherapy"

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss patient education prior to and during immunotherapy. This is a continued conversation from a previous episode that discussed findings from an ONS focus group that Orbaugh facilitated in August 2021; we’ve linked that in the episode notes. This podcast episode is supported by an educational grant from AstraZeneca. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. 

Lisa Kottschade, MSN, APRN, CNP, nurse practitioner at the Mayo Clinic in Rochester, MN, joins Chris Pirschel, ONS staff writer/producer, to discuss how immunotherapies are combined with other treatments, ways evolving treatment indications influence nursing practices, and how to keep patients safe when receiving combination immunotherapy treatments.

Learn about the process, risks, monitoring needs, and potential side effects of CAR T-cell therapy treatment of hematologic malignancies, with an emphasis on patient and family education. An interactive scenario and supporting resources reinforce learning.

“It’s really an exciting time to be in the field of oncology because we can have these specific drugs that target these specific variants rather than, back in the day, when we had to use kind of generic cancer therapies that weren’t specific for an individual’s cancer,” ONS member Suzanne Walker, PhD, CRNP, AOCN®, senior advanced practice provider and coordinator for thoracic malignancies at the Abramson Cancer Center at Penn Presbyterian Medical Center in Philadelphia, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about the latest updates in chemotherapy and immunotherapy treatments. Walker is one of the editors of ONS’s second edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice book.

ONS member Seth Eisenberg, RN, ASN, OCN®, BMTCN®, professional practice coordinator of infusion services at Seattle Cancer Care Alliance in Washington and member of the Puget Sound ONS Chapter, joins Stephanie Jardine, oncology clinical specialist at ONS, to discuss how to safely administer rituximab. This episode is part of an ongoing series about outpatient oncology drug infusion; the others are linked in the episode notes. 

Guide to Cancer Immunotherapy was developed by an expert collection of healthcare professionals and nursing leaders to provide nurses with in-depth knowledge on the principles of immunology, cancer and the immune system, and the history of immunotherapy.

ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educating oncology nurses about immunotherapy-related side effects, as well as the new resources available for providers and patients.

Learn more about best practices for personal protective equipment during administration, compounding, and spill management of checkpoint inhibitors.  

As the use of CAR T-Cell therapy grows, understanding the events involved, the adverse events associated with this therapy and evidence-based management strategies is critical. Use this resource to enhance your understanding of the process behind CAR T-Cell therapy and nursing considerations associated with the treatment. 

Follow a nurse through assessment and early interventions to better understand cytokine release syndrome, an adverse reaction associated with Car T-Cell therapy.